China Resources Pharmaceutical Group Co., Ltd. (stock code: 3320.HK) is a leading comprehensive pharmaceutical company in China, covering the production, distribution and retail of medicines and health products. Since listing, we have been included in several important capital market indexes, including: constituent stocks of Hang Seng Composite Market Index, Hang Seng China Mainland Healthcare Index, Hang Seng Healthcare Index, FTSE Global Stock Index (large-cap stocks), FTSE Global Index, FTSE Global Index, MSCI China Index, Hang Seng Hong Kong Stock Connect Index, Hang Seng Hong Kong Stock Connect China Mainland Company Index and Hang Seng Hong Kong Stock Connect Africa AH.
We have China Resources Pharmaceutical Business Group Co., Ltd. and China Resources Sanjiu Pharmaceutical Co., Ltd. (000999. SZ), China Resources Shuanghe Pharmaceutical Co., Ltd. (600062. SH), China Resources Jiang Zhong Pharmaceutical Group Co., Ltd. (600750. SH), Dong 'e Ejiao Co., Ltd. (000423. SZ), China Resources Zizhu Pharmaceutical Co., Ltd., China Resources Biomedical (0000003).
In 20 19, China Resources Pharmaceutical Group achieved operating income of HK$ 204.454 billion and profit of HK$ 5.098 billion.
Our manufacturing business covers the research and development, production and sales of pharmaceutical products. The product portfolio includes chemicals, traditional Chinese medicines, biological agents and nutritional health products, covering a wide range of therapeutic fields, including cardiovascular, digestive tract and metabolism, large-volume intravenous infusion, pediatrics, respiratory system and so on. Besides, we have many famous brands, including Sanjiu, Dong 'e Ejiao, Shuanghe, Jiang Zhong and Zizhu.
We operate a nationwide distribution network consisting of 65,438+078 logistics centers, covering 28 provinces, municipalities and autonomous regions in China. With our comprehensive product supply and extensive distribution network, we directly distribute products to hospitals and other medical institutions in China. In addition, we operate one of the largest retail pharmacy networks in China. It operates 850 national or regional high-quality brand retail pharmacies such as Huaruntang, Quanxin Medical Insurance, Lian Chain and Tongdetang.
Protecting human health and improving the quality of life is our lofty mission. Based on the opportunity of the development and transformation of China's medical and health industry, we should actively lay out the core areas and links of the industrial chain, persist in innovative development, give full play to the synergistic effect of comprehensive business layout, optimize resource allocation, strengthen international cooperation, promote transformation and upgrading, and constantly enhance the core competitiveness, and strive to become the leader of China's medical and health industry.